glp-1 and breast cancer risk Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence Breast cancer: GLP-1 use may
Description
This task fell to Lotte Bjerre Knudsen, a pharmaceutical scientist at Novo Nordisk
Other names for this medication class include: Glucagon-like peptide-1 agonists GLP-1 receptor agonists Incretin mimetics GLP-1 analogs How do GLP-1s work
Novo Nordisk also offers a pill approved by Health Canada to treat Type 2 diabetes that contains semaglutide and is sold under the name Rybelsus
10.1111/bph.13407 Br
